Tokyo, Japan

Yosuke Kurashima

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Yosuke Kurashima

Introduction

Yosuke Kurashima is a distinguished inventor located in Tokyo, Japan. With a focus on medical applications, he has made significant contributions to the field through his innovative patented technologies. Currently affiliated with The University of Tokyo, he specializes in the development of antibodies for therapeutic use.

Latest Patents

Yosuke Kurashima holds two notable patents. The first patent pertains to an antibody to a fibrosis-related molecule along with its medical applications. This innovative antibody is specifically designed to bind to CHL1 protein, offering the ability to neutralize its interaction with fibroblasts. The second patent mirrors the first, emphasizing the significance of the CHL1 protein in fibrosis-related therapeutic contexts.

Career Highlights

Throughout his career, Kurashima has demonstrated a unique ability to bridge the gap between scientific research and practical medical application. His work at The University of Tokyo has positioned him at the forefront of medical research, particularly in the field of fibrosis, which poses significant health challenges.

Collaborations

Yosuke Kurashima has been collaborating with his coworker, Hiroshi Kiyono, to advance the research involving CHL1 protein and its potential medical applications. Their partnership reflects a synergy of expertise that is essential for groundbreaking innovations in the biomedical field.

Conclusion

In summary, Yosuke Kurashima stands out as an innovative inventor whose work is shaping the future of medical treatments for fibrosis-related conditions. His patents represent a significant advancement in understanding and targeting fibrosis, showcasing the impactful intersection of research and practical application in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…